Indications |
Oral Dissolution of cholesterol-rich gallstones Adult: 6-12 mg/kg daily as a single dose at bedtime or in 2-3 divided doses continued for 3-4 mth after radiological disappearance of stones. Doses may be divided unequally with a higher dose given before bedtime to counteract increase in biliary cholesterol saturation which occurs in early morning. Max: 15 mg/kg. Hepatic impairment: Chronic liver disease (except primary biliary cirrhosis): use with caution. Oral Primary biliary cirrhosis Adult: 10-15 mg/kg daily in 2-4 divided doses. Oral Prophylaxis of gallstones in patients undergoing rapid weight loss Adult: 300 mg bid. Hepatic impairment: Chronic liver disease (except primary biliary cirrhosis): use with caution. |
Contraindications |
Calcified and pigment gallstones, radio opaque gallstones. Nonfunctioning gall bladders; chronic liver and peptic ulcer disease. Inflammatory disease of colon and small intestine. Pregnancy. |
Warnings / Precautions |
50% of successfully treated patients will develop further gallstones within 10 yr. Lactation. |
Adverse Reactions |
Diarrhoea, pruritus, nausea, vomiting, gallstone calcification. |
Drug Interactions |
Cholestyramine, charcoal and antacids may reduce effectiveness. Aluminum-based antacids may reduce absorption. Oestrogens and clofibrate may counteract effectiveness of ursodeoxycholic acid by increasing cholesterol elimination in bile. Possible increase in ciclosporin serum concentration. Decreased effectiveness of dapsone. Possible decrease in serum ciprofloxacin and nitrendipine. See Below for More ursodeoxycholic acid Drug Interactions |
Mechanism of Actions |
Ursodeoxycholic acid suppresses hepatic synthesis and secretion of cholesterol and also inhibits intestinal absorption of cholesterol. Absorption: Rapidly and completely absorbed from the GI tract. Distribution: Protein binding: 96-98%. Undergoes enterohepatic recycling. Metabolism: Partly conjugated in the liver before being excreted into the bile. Free and conjugated forms undergo 7a-dehydroxylation to lithocholic acid under the influence of gut bactera. Some are reabsorbed and then further conjugated and sulfated by the liver. Excretion: Faeces. |
Administration |
Should be taken with food. |
ATC Classification |
A05AA02 - ursodeoxycholic acid ; Belongs to the class of bile acids. |
Available As |
|
Ursodeoxycholic Acid
Post Review about Ursodeoxycholic Acid Click here to cancel reply.
Ursodeoxycholic Acid Containing Brands
Ursodeoxycholic Acid is used in following diseases
Drug - Drug Interactions of Ursodeoxycholic Acid
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.